What does CUSIP 77313F106 represent in this 13F holders report?

CUSIP 77313F106 is the security identifier for RCKT - ROCKET PHARMACEUTICALS, INC. - Common Stock used to aggregate holder disclosures.

How many institutions held RCKT - ROCKET PHARMACEUTICALS, INC. - Common Stock in Q1 2018?

55 institutional investors reported RCKT - ROCKET PHARMACEUTICALS, INC. - Common Stock for Q1 2018. Use the holders table for investor-level position and value details.

ROCKET PHARMACEUTICALS, INC. - Common Stock (RCKT)

CUSIP: 77313F106

Q1 2018 13F Holders as of 31 Mar 2018

Type / Class: Equity / Common Stock
Shares outstanding: 109,265,652
Total 13F shares: 27,976,061
Share change: +27,976,061
Total reported value: $502,091,019
Put/Call ratio: 29%
Price per share: $18.75
Number of holders: 55
Value change: +$502,091,019
Number of buys: 55

Quarterly Holders Quick Answers

What is CUSIP 77313F106?
CUSIP 77313F106 identifies RCKT - ROCKET PHARMACEUTICALS, INC. - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q2 2018

Recent filing periods for CUSIP 77313F106:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of RCKT - ROCKET PHARMACEUTICALS, INC. - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

No top shareholder records were found across 13F, 13D/G, and Forms 3/4/5 for this issuer.

Institutional Holders of ROCKET PHARMACEUTICALS, INC. - Common Stock (RCKT) as of Q1 2018

As of 31 Mar 2018, ROCKET PHARMACEUTICALS, INC. - Common Stock (RCKT) was held by 55 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 27,976,061 shares. The largest 10 holders included RTW INVESTMENTS, LP, Boxer Capital, LLC, BRIDGER MANAGEMENT, LLC, Cormorant Asset Management, LP, ADAGE CAPITAL PARTNERS GP, L.L.C., Ghost Tree Capital, LLC, ORBIMED ADVISORS LLC, VANGUARD GROUP INC, PRICE T ROWE ASSOCIATES INC /MD/, and CITADEL ADVISORS LLC. This page lists 55 institutional shareholders reporting positions in this security for the Q1 2018 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q1 2018 vs Q4 2025 Across Filers

Q4 2025 holders

182

Q1 2018 holders

Holder diff

-127

Investor	Q4 2025 Shares	Q1 2018 Shares	Share Diff	Share Chg %	Q4 2025 Value $	Q1 2018 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.